These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14989426)

  • 1. Effects of DMARDs on IL-1Ra levels in rheumatoid arthritis: is there any evidence?
    Cutolo M
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S26-31. PubMed ID: 14989426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IL-1Ra: its role in rheumatoid arthritis].
    Cutolo M
    Reumatismo; 2004; 56(1 Suppl 1):41-5. PubMed ID: 15201939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro modulation of cytokine, cytokine inhibitor, and prostaglandin E release from blood mononuclear cells and synovial fibroblasts by antirheumatic drugs.
    Seitz M; Loetscher P; Dewald B; Towbin H; Baggiolini M
    J Rheumatol; 1997 Aug; 24(8):1471-6. PubMed ID: 9263137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-interleukin-1 therapy in rheumatic diseases.
    Dayer JM; Feige U; Edwards CK; Burger D
    Curr Opin Rheumatol; 2001 May; 13(3):170-6. PubMed ID: 11333344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anakinra: a review of its use in the management of rheumatoid arthritis.
    Waugh J; Perry CM
    BioDrugs; 2005; 19(3):189-202. PubMed ID: 15984903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
    Bresnihan B
    BioDrugs; 2001; 15(2):87-97. PubMed ID: 11437678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes.
    Seitz M; Zwicker M; Loetscher P
    Arthritis Rheum; 1998 Nov; 41(11):2032-8. PubMed ID: 9811059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Baggiolini M; Gerber NJ
    Br J Rheumatol; 1995 Jul; 34(7):602-9. PubMed ID: 7670776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
    Zoń-Giebel A; Kotulska A; Giebel S; Cader SA; Kucharz EJ
    Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased IL-1 receptor antagonist (IL-1ra) production and decreased IL-1 beta/IL-1ra ratio in mononuclear cells from rheumatoid arthritis patients.
    Shingu M; Fujikawa Y; Wada T; Nonaka S; Nobunaga M
    Br J Rheumatol; 1995 Jan; 34(1):24-30. PubMed ID: 7881833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
    Seitz M; Zwicker M; Wider B
    J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
    Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
    Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis.
    Corr M; Boyle DL; Ronacher LM; Lew BR; van Baarsen LG; Tak PP; Firestein GS
    Ann Rheum Dis; 2011 May; 70(5):858-63. PubMed ID: 21216819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis.
    Cutolo M; Bisso A; Sulli A; Felli L; Briata M; Pizzorni C; Villaggio B
    J Rheumatol; 2000 Nov; 27(11):2551-7. PubMed ID: 11093433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].
    Fiocco U; Vezzù M; Cozzi L; Todesco S
    Reumatismo; 2004; 56(1 Suppl 1):62-73. PubMed ID: 15201942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.
    Scuderi F; Convertino R; Molino N; Provenzano C; Marino M; Zoli A; Bartoccioni E
    Autoimmunity; 2003 Mar; 36(2):71-7. PubMed ID: 12820688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.